Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Böltz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nitric Oxide : Biology and Chemistry|June 17, 2014
Working with "H2S": facts and apparent artifactsRudolf Wedmann, Sarah Bertlein, Igor Macinkovic, et al.
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.
Cells|April 25, 2025
Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus ErythematosusHannah Schenker, Lukas Kuhlmann, Dorothee Kaudewitz, et al.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Nature Medicine|September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosusAndreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
Nature Medicine|January 7, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Melanie Hagen, Andreas Wirsching, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
JAMA Neurology|January 20, 2026
Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Agnes Bonifacius, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nitric Oxide : Biology and Chemistry|June 17, 2014
Working with "H2S": facts and apparent artifactsRudolf Wedmann, Sarah Bertlein, Igor Macinkovic, et al.
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.
Cells|April 25, 2025
Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus ErythematosusHannah Schenker, Lukas Kuhlmann, Dorothee Kaudewitz, et al.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Nature Medicine|September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosusAndreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
Nature Medicine|January 7, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Melanie Hagen, Andreas Wirsching, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
JAMA Neurology|January 20, 2026
Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Agnes Bonifacius, et al.
Pageof 1